Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Remitly Global Inc (RELY) vs Tempus AI (TEM) Price & Performance

Remitly Global IncTrade

Price performance (Past 24H)

Key statistics

Remitly Global Inc vs Tempus AI — how do they compare? Remitly Global Inc trades at $23.37 (market cap $5.02B), while Tempus AI trades at $47.13 (market cap $8.80B). The key difference: Tempus AI is the larger of the two by market cap, and Remitly Global Inc is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals.

RELYTEM
Market Cap
$5.02B$8.80B
Sector
TechnologyBroad Market / Factor
52-Week High
$25.23$103.25
52-Week Low
$12.20$42.37
Enterprise Value
$4.41B$9.47B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Remitly Global Inc

RELY trades at $23.83, down 1.24% on the day, with a bullish technical signal from moving averages. The company has demonstrated a strong turnaround, achieving profitability in 2025 with net income of $67.93 million after years of losses. Revenue growth is robust, reaching $1.64 billion in 2025, with positive cash flow from operations of $325.08 million. Recent news highlights expansion, including a new license in the UAE and raised full-year guidance for 2026.

The outlook is positive, driven by accelerating revenue growth, market share gains in the remittance sector, and a clear path to sustained profitability. Key risks include intense competition from established payment giants and execution challenges in international expansion. With a consensus analyst price target of $28.50 implying significant upside, the stock presents a growth opportunity, though investors should be mindful of its premium valuation multiples.

Tempus AI

Tempus AI (TEM) trades at $48.41, down 7.74% amid market reaction to its $1.5 billion acquisition of Personalis. The stock shows bearish technical signals with negative moving averages and oversold RSI levels. Fundamentally, the company maintains strong revenue growth ($1.27B in 2025) but faces significant losses (-$245M net income) and negative margins. Recent news highlights strategic expansion in cancer diagnostics through AI-driven platforms.

Despite analyst optimism (61.5% buy ratings, $68.50 target), TEM faces execution risks from the major acquisition and persistent profitability challenges. The stock's current discount to target offers potential upside if integration succeeds, but high cash burn and competitive pressures require careful monitoring for investors considering entry at these levels.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Remitly Global Inc

Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. Its revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.

Read more on RELY

About Tempus AI

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Read more on TEM